Navigation Links
The Benefits of Alcohol Consumption Questioned

To analyze the benefits of alcohol consumption and cardiovascular disease researchers studied nearly 2,500 seniors ages 70 to 79 who consumed // moderate levels of alcohol (one to seven drinks per week), consumed high levels of alcohol (more than eight drinks per week), and did not consume any alcohol.

Researchers say, their study is the first to focus on the association between alcohol intake and inflammatory markers such interleukin-6 (IL-6), C-reactive protein (CPR), tumor necrosis factor-alpha (TNF-alpha) and plasminogen activator inhibitor (PAI-1).

Results showed moderate drinkers had the lowest levels of IL-6 and CPR in comparison to non-drinkers. However, those who consumed high levels of alcohol had higher levels of IL-6 and CPR in comparison to non-drinkers and moderate drinkers. Specialists say, IL-6 and CPR are strong predictors of heart attacks and other poor health outcomes in middle-aged and older adults.The American Heart Association cautions individuals who do not currently consume alcohol to avoid starting to drink alcohol.

In conclusion researchers say their results suggest there may be a biological explanation for the link between alcohol consumption and heart disease.
'"/>




Page: 1

Related medicine news :

1. Benefits in fertility procedures
2. Benefits of Vitamin Supplements Unclear
3. Benefits of Eating Whole Grains, Fruits and Vegetables
4. Benefits of Nitric Oxide in the Treatment of Premature Infants
5. Benefits and Risks of Asthma Treatment Questioned
6. Benefits Of The Worlds Most Widely Used Beverage
7. Drug In Asthma inhaler Found To Counteract Benefits
8. The Benefits Of Keyhole Surgery
9. The Benefits Of A Stretch
10. A Reduction In Calories Found To Yield More Benefits
11. The Benefits Of Soy
Post Your Comments:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...nconvenient Truth" to heated Congressional debates...fuels, the issue of coal's place in supplying Amer...portance in recent months. A research institute a..., has been exploring ways to increase the efficien...
..., Western Australia, are bracing themselves for a ...ildren within a day . The fear comes after three ... fatal strain in the past 72 hours. Staff at The ...mitted its Emergency Department had been bursting ...
...recovered from the bottom of a two-kilometre thick...was much warmer at some point during the last Ice ...the trees, plants and insects of a boreal forest e...00,000 years old. Previously, the youngest evidenc...
...rsity researcher is experimenting with ways to add...we like about our favourite snacks . Sajid Alavi ...ustry at K-State's College of Agriculture. His e...ocessing, which is used to make products from chee...
Other Medicine News:Health News:An Inconvenient Truth-Coal to Liquid 2Health News:Flu Outbreak Among Children Feared in Western Australia 2Health News:Now, Fibre-enriched Tasty Snacks in the Making 2
(Date:9/4/2008)...vival Data for Ipilimumab to be Presented, PRINCE...ex, Inc.,(Nasdaq: MEDX ) announced today that nin...ional anti-CTLA-4 antibody, in melanoma are schedu... Congress of the European Society,for Medical Onco...ockholm.,Many of the following abstracts will incl...
(Date:9/4/2008)...emain on Schedule with Two Abstracts Accepted for ...in November 2008, BRIDGEWATER, N.J., Sept. 4 /PRN...ialty pharmaceutical company focused on the treatm... announced the appointment of,Peter L. Garrambone,...Garrambone,s career includes more than 50 pharmace...
(Date:9/3/2008)...t. 3 /- Simcere,Pharmaceuti...d supplier of,branded generic pharmaceuticals and ...roduct Endu (also known as Endostar) in China,ann...al study., At the request of the SFDA, Simcere in...ate the safety and therapeutic efficacy of Endu, a...
(Date:9/3/2008)... National Vascular Disease Awareness Month, CHARL... Pharmaceuticals,LLC, a clinical-stage drug-develo...eatment of unmet medical needs, announced today th... clinical trial of its lead drug,candidate trans s...00725881,on the clinicaltrials.gov Website, is inv...
Breaking Medicine Technology:Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Aida Pharmaceuticals Inc Announces Availability of Downloadable Corporate Synopsis on its Website 17404 1Aida Pharmaceuticals Inc Announces Availability of Downloadable Corporate Synopsis on its Website 17404 2Pathwork 28R 29 Diagnostics Launches Genomics Based Test For Hard To Identify Tumors Through Its CLIA Certified Laboratory 4765 1Pathwork 28R 29 Diagnostics Launches Genomics Based Test For Hard To Identify Tumors Through Its CLIA Certified Laboratory 4765 2Pathwork 28R 29 Diagnostics Launches Genomics Based Test For Hard To Identify Tumors Through Its CLIA Certified Laboratory 4765 3Smiths Medical to Promote and Distribute Abbotts FreeStyle Navigator Continuous Glucose Monitoring System 4761 1Smiths Medical to Promote and Distribute Abbotts FreeStyle Navigator Continuous Glucose Monitoring System 4761 2Smiths Medical to Promote and Distribute Abbotts FreeStyle Navigator Continuous Glucose Monitoring System 4761 3Smiths Medical to Promote and Distribute Abbotts FreeStyle Navigator Continuous Glucose Monitoring System 4761 4Detour 28R 29 Unveils Snack Size Protein Bar 17400 1Detour 28R 29 Unveils Snack Size Protein Bar 17400 2
...A NIGUEL, Calif.--(BUSINESS WIRE)--Apr 19, 2007 - ...d the presentation of,data by researchers at Loma ...edical and Research Center and Duke University,sho...tioxidants,AEOL 10113, demonstrated protection of...cells treated with radiation therapy. The study,al...
...ING RIDGE, N.J., April 19, 2007 /PRNewswire-FirstC...sey-based,biopharmaceutical company focused on acq...ncer compounds, announced data from its,preclinica...ctivation for the treatment of solid and hematolog...ster at the April 2007,Annual Meeting of the Ameri...
Other Medicine Technology:Aeolus Pharmaceuticals' AEOL 10113 Demonstrates Potential as a,Protector of Healthy Normal Cells from Cancer Radiation Therapy 2Aeolus Pharmaceuticals' AEOL 10113 Demonstrates Potential as a,Protector of Healthy Normal Cells from Cancer Radiation Therapy 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 2VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 4VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 5
Ties improve torso fit and transfer weight to waist and hips. Ties are 1"W cotton woven for flexibility and sewn at an angle across the full width of the two back sections for durability.
Use this workhorse apron where 360 of protection from direct and scatter radiation is required.
Mini Aprons are half aprons with an easy-on, easy-off Velcro-style closure that fastens securely in seconds. Color-coded sizes for easy identification. Offers 0.5 mm Pb equivalent protection.
...IA, a rapid and simple test for rotavirus infectio...t. The Pathfinder Rotavirus Enzyme Immunoassay Di... of rotavirus directly from patient specimens. Th...iy of monoclonal antibodies with the speed and eff...
Medicine Products: